The Chelator in RDC (Radionuclide Drug Conjugate) is used to link the radionuclide and the targeting molecule in order to integrate the targeting and effectiveness of RDC. A number of chelators are now applied in the conjugation process.

Rdcthera offers chelators screening and synthesis services, for lateral chelator conjugation services, including covalently binding antibodies, small molecules, and peptides to metal ions.

Learn more: chelators hbed

RDC (Radionuclide Drug Conjugate) is a newly discovered concept for clinical cancer diagnosis and treatment. The tumor cell is a classic in vitro model for preclinical investigations.

Rdcthera has established multiple tumor cell lines and organ models for tumor inhibition potency analysis. Learn more：Tumor Inhibition Potency